Latest Diabetic retinopathy Stories
DME is the third approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., July 29, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., July 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment
UITHOORN, The Netherlands, July 14, 2014 /PRNewswire/ -- - HOYA signs a multiple-year contract with Eye diagnostics innovator i-Optics to offer opticians the EasyScan 3
TARRYTOWN, N.Y., June 27, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
ATLANTA, June 23, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
GAITHERSBURG, Md., June 16, 2014 /PRNewswire/ -- The 74th Scientific Session of the American Diabetes Association (ADA) was the setting that released the initial results from the recently completed
TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
VANCOUVER, June 9, 2014 /PRNewswire/ - iCo Therapeutics Inc.
Major population study finds vasodilators may raise likelihood of age-related macular degeneration SAN FRANCISCO, May 28, 2014 /PRNewswire-USNewswire/ -- There may be a connection between taking
- A gift; a largess; a gratuity; a present; a dole.